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There is increasing evidence that fluid overload and
acute kidney injury (AKI) are associated but the exact
cause-effect relationship remains unclear. Wang and
colleagues analysed patients admitted to 30 intensive
care units in China and found that fluid accumulation
was independently associated with an increased risk
of AKI and mortality. This commentary focuses on the
close pathophysiological link between AKI and fluid
overload and discusses the implications for clinical
practice. It outlines some of the challenges, including
the difficulty in diagnosing fluid overload reliably with
current methods, and stresses the importance of
personalised fluid therapy with physiological end-points
to avoid the deleterious effects of fluid overload.depend on the specific type of fluid has not been stud-
ied. It is plausible that fluid overload as a result of exces-Fluids are the second most common intervention in
acutely ill patients (after oxygen). Whilst the benefits of
early fluid resuscitation in patients with shock and acute
kidney injury (AKI) have been accepted, uncertainty
remains about the optimal type, volume and timing of
fluid delivery. There is growing evidence that fluid ad-
ministration beyond the correction of hypovolaemia is
associated with increased morbidity, a longer hospital
stay and mortality. In a recent article in Critical Care,
Wang et al. analysed the data of 2526 patients admitted
to 30 intensive care units (ICUs) in China and showed
that even relatively small degrees of fluid overload were
independently associated with an increased risk of AKI
and mortality [1]. Others have shown associations be-
tween fluid overload and poor outcomes in patients with
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undergoing major surgery [2–6].
Although there is now little doubt that fluid overload
is associated with AKI, it is difficult to disentangle the
cause-effect relationship. Furthermore, translating the
results into clinical practice is very challenging, espe-
cially since some important issues are still unresolved.
First, defining fluid overload is not straightforward. By
convention, most studies in the literature, including the
study by Wang et al. [1], defined fluid overload by a per-
centage increase in body weight from day of admission
to the ICU. However, this assumes that patients were
intravascularly replete on admission (which is often not
the case). It also ignores any insensible losses as well as
fluid administration in the pre-ICU setting.
Second, whether the consequences of fluid overload
sive crystalloid administration has a different impact
compared with fluid accumulation following infusion of
colloids or massive transfusion of blood products. More
data are necessary. The timing of volume administration
may also be relevant. A positive fluid balance of 5 litres
over an initial 24-hour period followed by no further
fluid gain may have a different outcome compared with
the same net balance over a period of days.
Third, fluid overload may result from overzealous fluid
administration or oliguria or a combination of the two.
The differentiation is important since fluid overload
caused by excessive fluid therapy is potentially avoidable
whereas fluid overload as a result of oliguria may reflect
AKI and may not be easily modifiable without RRT [7].
Most studies have not distinguished between the two. In
a recent retrospective analysis, it was demonstrated that
fluid administration, rather than low urine output, was
independently associated with progression from AKI
stage I to stage III [8]. Clearly, more detailed work isticle is distributed under the terms of the Creative Commons Attribution 4.0
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Finally, the fact that fluid overload is associated with
AKI does not prove causality. One key problem is that
the effects of volume overload and the effects of AKI are
similar. Both lead to multi-organ dysfunction. They also
often have the same denominator, including endothelial
dysfunction due to inflammation or ischaemia/reperfu-
sion injury with decay and shedding of the glycocalyx
and subsequent capillary leakage [9]. Patients with more
severe endothelial dysfunction tend to develop both fluid
overload and AKI following fluid administration. Im-
portantly, hypervolaemia may stretch the vascular wall
and worsen vascular permeability, possibly by atrial
natriuretic peptide-induced damage to the glycocalyx
[10] (Fig. 1). Unpicking this vicious circle can be very
difficult.
Nevertheless, the study by Wang et al. does confirm
what other studies have shown previously that a positive
fluid balance is associated with worse outcomes. The
crucial question for clinical practice is how to ensure ap-
propriate and timely correction of hypovolaemia without
causing fluid overload. Unfortunately, the tools to guide
fluid management and to inform the clinical team when
fluid administration is no longer beneficial are inad-
equate. Central venous pressure (CVP) or dynamic tech-
niques like fluid responsiveness or echocardiography are
often used. However, the CVP does not accurately reflect
intravascular volume status and can be misleading [11].
Measuring changes in pulse pressure and stroke volume
may provide very useful information for assessing pre-
load and fluid responsiveness but does not diagnose or
quantify fluid overload either. Crucially, these techniques
are not readily available outside critical care areas.
Cumulative fluid balance gives an indication about theFig. 1 Interconnected relationship between acute kidney injury and fluid o
systemic inflammatory response syndromefluid input–output relationship but does not correct for
non-measurable losses, is often inaccurate [12] and does
not indicate whether a patient is intravascularly hypovol-
aemic, euvolaemic or overloaded.
In the absence of any sophisticated tools to confirm
euvolaemia or diagnose fluid overload, initial fluid resus-
citation should be guided by an assessment of fluid re-
sponsiveness followed by fluid therapy titrated against
individualized end-points [13, 14]. The passive leg rais-
ing (PLR) manoeuvre (i.e., internal fluid loading which is
reversible) coupled with real-time stroke volume moni-
toring has been recommended to assess the need for
fluid therapy [14].
There is some prospect that novel biomarkers may
also have a role to prevent fluid overload. Mekontso
Dessap et al. randomly assigned 304 mechanically
ventilated patients to a strategy driven by B-type
natriuretic peptide (BNP) or usual care [15]. Patients
in the BNP-led cohort received diuretics and fluid
restriction on days when their BNP was at least
200 pg/ml. Fluid balance was more negative and
time to successful extubation was shorter in this
group.
Conclusions
Fluid overload, AKI and poor outcomes are clearly asso-
ciated. However, whether AKI has caused fluid overload
or vice versa can be difficult to determine. Better tools
are necessary to measure intravascular volume status.
Until then, fluid therapy needs to be personalised with
physiological end-points, guided by dynamic tests like
PLR manoeuvre, and monitored by using cumulative
fluid balance coupled, where possible, with daily weights
to avoid the adverse outcomes associated with fluid
overload.verload. AKI acute kidney injury, ANP atrial natriuretic peptide, SIRS
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